Teplizumab-Mzwv
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult Patients.
Journal: Diabetes, obesity & metabolism
Published: January 19, 2026
The Role of the Diabetes Care and Education Specialist in Screening and Monitoring for Type 1 Diabetes.
Journal: The science of diabetes self-management and care
Published: May 24, 2025
Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice.
Journal: Hormone research in paediatrics
Published: February 06, 2024
Journey of Teplizumab: A Promising Drug in the Treatment of Type 1 Diabetes Mellitus.
Journal: Current diabetes reviews
Published: May 11, 2023
Teplizumab Therapy to Delay the Onset of Type 1 Diabetes.
Journal: Cardiology in review
Published: May 09, 2023
Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function.
Journal: Diabetes care
Published: April 14, 2023
Teplizumab-mzwv.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: February 13, 2023
Teplizumab (Tzield) to delay onset of type 1 diabetes.
Journal: The Medical letter on drugs and therapeutics
Published: January 11, 2023
Showing 1-10 of 10
Last Updated: 04/28/2026